PubMed COVID-19 Clinical Care

Research highlight: Impact of COVID-19 Disease Control Committee (CDCC) policies on prevention of the disease using Bayes network inference in west of Iran

Tuesday, March 19, 2024 - 4:00 AM

No abstract

RECOVERY trial: COVID-19

Tuesday, March 19, 2024 - 4:00 AM

No abstract

Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study

Tuesday, March 19, 2024 - 4:00 AM

BACKGROUND: Ritonavir-boosted Nirmatrelvir (NMV-r), a protease inhibitor with in vitro activity against SARS-CoV-2, can reduce risk of progression to severe COVID-19 among high-risk individuals infected with earlier variants, but less is known about

Right Femoral Fragility Fracture in an Adolescent with Vitamin D Deficiency from COVID-19 Pandemic-Related Confinement

Tuesday, March 19, 2024 - 4:00 AM

CONCLUSION: A high degree of suspicion is needed to rule out secondary causes in adolescents who present with unusual fragility fractures.

Reliability and validity of the Patient Health Questionnaire-4 scale and its subscales of depression and anxiety among US adults based on nativity

Tuesday, March 19, 2024 - 4:00 AM

CONCLUSIONS: The PHQ-4 and its subscales are reliable and valid measures to screen anxiety and depression symptoms in the general US adult population, especially in foreign-born individuals during the COVID-19 pandemic.

Remote Delivery of Mindful Movement Within Healthcare Systems: Lessons Learned From the Veterans Health Administration

Tuesday, March 19, 2024 - 4:00 AM

Mindful Movement approaches have been a growing part of the Veterans Health Administration (VA). Innovations in tele-health technology had been an important initiative before the public health emergency to meet the needs of rural veterans as well as

Rapid assessment of data systems for COVID-19 vaccination in WHO African Region

Monday, March 18, 2024 - 4:00 AM

No abstract

RE: Post-acute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study

Monday, March 18, 2024 - 4:00 AM

No abstract

Rapid and sensitive detection of SARS-CoV-2 IgM through luciferase luminescence on an automatic platform

Monday, March 18, 2024 - 4:00 AM

SARS-CoV-2 has brought a global health crisis worldwide. IgM is an early marker in sera after the infections, and the detection of IgM is crucial to assist diagnosis and evaluate the vaccination clinically. Herein, we developed an automated platform

Real-life experience on COVID-19 and seasonal influenza vaccines co-administration in the vaccination hub of the University Hospital of Palermo, Italy

Monday, March 18, 2024 - 4:00 AM

With the pandemic, there has been a global reduction in influenza virus circulation, with WHO reporting, during 2021/22 season, laboratory testing positivity rate for influenza of less than 3%. Influenza surveillance systems anticipated a peak of